301 related articles for article (PubMed ID: 31400613)
1. Strategies for surface modification of gelatin-based nanoparticles.
Mahmoudi Saber M
Colloids Surf B Biointerfaces; 2019 Nov; 183():110407. PubMed ID: 31400613
[TBL] [Abstract][Full Text] [Related]
2. Implications of protein- and Peptide-based nanoparticles as potential vehicles for anticancer drugs.
Elzoghby AO; Elgohary MM; Kamel NM
Adv Protein Chem Struct Biol; 2015; 98():169-221. PubMed ID: 25819280
[TBL] [Abstract][Full Text] [Related]
3. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
Elzoghby AO
J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
[TBL] [Abstract][Full Text] [Related]
4. Polysaccharide nanoparticles for protein and Peptide delivery: exploring less-known materials.
dos Santos MA; Grenha A
Adv Protein Chem Struct Biol; 2015; 98():223-61. PubMed ID: 25819281
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting strategies for chitosan-based nanoparticles.
Zhang X; Yang X; Ji J; Liu A; Zhai G
Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
[TBL] [Abstract][Full Text] [Related]
6. Recent advancement of gelatin nanoparticles in drug and vaccine delivery.
Sahoo N; Sahoo RK; Biswas N; Guha A; Kuotsu K
Int J Biol Macromol; 2015 Nov; 81():317-31. PubMed ID: 26277745
[TBL] [Abstract][Full Text] [Related]
7. Mechanical properties of gelatin nanoparticles in dependency of crosslinking time and storage.
Weiss AV; Fischer T; Iturri J; Benitez R; Toca-Herrera JL; Schneider M
Colloids Surf B Biointerfaces; 2019 Mar; 175():713-720. PubMed ID: 30612047
[TBL] [Abstract][Full Text] [Related]
8. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
Kouchakzadeh H; Safavi MS; Shojaosadati SA
Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
10. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
Bayram B; Ozgur A; Tutar L; Tutar Y
Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
[TBL] [Abstract][Full Text] [Related]
12. Preparation of gelatin nanoparticles by two step desolvation method for application in photodynamic therapy.
Carvalho JA; Abreu AS; Ferreira VTP; Gonçalves EP; Tedesco AC; Pinto JG; Ferreira-Strixino J; Beltrame Junior M; Simioni AR
J Biomater Sci Polym Ed; 2018 Aug; 29(11):1287-1301. PubMed ID: 29561222
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery.
Klippstein R; Pozo D
Adv Protein Chem Struct Biol; 2015; 98():145-68. PubMed ID: 25819279
[TBL] [Abstract][Full Text] [Related]
14. Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines.
Battistella C; Klok HA
Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28444959
[TBL] [Abstract][Full Text] [Related]
15. Progress and challenges towards targeted delivery of cancer therapeutics.
Rosenblum D; Joshi N; Tao W; Karp JM; Peer D
Nat Commun; 2018 Apr; 9(1):1410. PubMed ID: 29650952
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
Sultana S; Khan MR; Kumar M; Kumar S; Ali M
J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs.
Raza F; Siyu L; Zafar H; Kamal Z; Zheng B; Su J; Qiu M
Curr Pharm Des; 2022; 28(5):380-394. PubMed ID: 34727851
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
Jia F; Liu X; Li L; Mallapragada S; Narasimhan B; Wang Q
J Control Release; 2013 Dec; 172(3):1020-34. PubMed ID: 24140748
[TBL] [Abstract][Full Text] [Related]
19. Polymeric protective agents for nanoparticles in drug delivery and targeting.
Mogoşanu GD; Grumezescu AM; Bejenaru C; Bejenaru LE
Int J Pharm; 2016 Aug; 510(2):419-29. PubMed ID: 26972379
[TBL] [Abstract][Full Text] [Related]
20. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
